Cargando…
Pharmacological Therapies and Their Clinical Targets in Irritable Bowel Syndrome With Diarrhea
Irritable bowel syndrome (IBS) is one of the most common disorders of the gut-brain axis, which affects approximately 4% of the global population. The Rome IV criteria define IBS as chronic or recurrent abdominal pain associated with altered bowel habits. Patients can be categorized in four subtypes...
Autores principales: | , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7935509/ https://www.ncbi.nlm.nih.gov/pubmed/33679391 http://dx.doi.org/10.3389/fphar.2020.629026 |